Microalbuminuria y excreción urinaria de albúmina en la práctica clínica

• Rodrigo Tagle ^[1] ; Fernando González ^[2] ; Mónica Acevedo ^[1]
  1. [1] Pontificia Universidad Católica de Chile

     Pontificia Universidad Católica de Chile

     Santiago, Chile

     
  2. [2] Hospital del Salvador

     Hospital del Salvador

     Santiago, Chile

     
• Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 140, Nº. 6, 2012, págs. 797-805
• Idioma: español
• Títulos paralelos:
  • Microalbuminuria and urinary albumin excretion in clinical practice
• Enlaces
  • Texto completo
• Resumen

  • Background: Microalbuminuria is a new tool in the management of patients with diabetes mellitus or hypertension. Microalbuminuria is an easily measured biomarker in a urine sample. Urinary albumin to creatinine ratio in first morning urine sample correlates with 24 hours urinary albumin excretion, but it is easier to obtain, and can identify hypertensive or diabetic patients with high risk for cardiovascular events. Therapeutic interventions such as renin angiotensin system blockade have demonstrated their usefulness in reducing urinary albumin excretion in clinical studies. It would be advisable to incorporate urinary albumin to creatinine ratio to the routine clinical monitoring of patients with cardiovascular risk, such as those with hypertension and diabetes mellitus.